No evidence for occult HBV infection in hepatitis B vaccine non-responders
-
Mohammad Reza Aghasadeghi
,
Mohammad Banifazl
,
Arezoo Aghakhani
,
Ali Eslamifar
,
Rouhollah Vahabpour
,
Amitis Ramezani
Abstract
Background and Objective: Although hepatitis B vaccine immunogenicity is high, certain risk factors such as age, tobacco consumption, obesity and genetic background have been associated with low responsiveness to HBV vaccine. We aimed to evaluate the role of occult hepatitis B virus (HBV) infection in non-responder adults to HBV vaccine in a low endemic area for HBV.
Material and Methods: A total of 52 subjects who were non-responder to HBV vaccine were enrolled in the study. HBsAg, anti-HBs and anti-HBc were tested in all subjects. The presence of HBV-DNA was determined in plasma samples by real- time PCR.
Results: A total of 52 cases with median age 34 years were enrolled in the study. 63.5% of patients were male and 36.5% were female. Isolated anti-HBc (HBsAg negative, anti-HBs negative and anti-HBc positive) was detected in 3.8% of cases. HBV-DNA was not detected in our cases.
Conclusion: This study showed no evidence of occult HBV infection in our HBV vaccine non-responders even in cases with isolated anti-HBc.
Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745.
Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 2007; 16: 403-406.
Merat S, Malekzadeh R, Rezvan H, Khatibian M.Hepatitis B in Iran. Arch Iran Med 2000; 3: 192-201.
Hadler SC. Vaccines to prevent hepatitis B and hepatitis A virus infections. Infect Dis Clin North Am 1990; 4: 29-46.
Shapiro CN, Margolis HS. Hepatitis B epidemiology and prevention. Epidemiol Rev 1990; 12: 221-7.
Stevens CE. Immunoprophylaxis of hepatitis B virus infection. Semin Pediatr Infect Dis 1991; 2: 135-9.
Goncalves L, Albarran B, Salmen S, Borges L, Fields H, Montes H, et al. The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation. Virology 2004; 326:20-28.
Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population based study. Arch Iran Med 2009;12:225-231.
Roome AJ, Walsh SJ, Cartter ML, Hadler JL. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA 1993; 270:2931-2934.
Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 1993; 270:2935-2939.
Yen YH, Chen CH, Wang JH, Lee CM, Changchien CS, Lu SN. Study of hepatitis B (HB) vaccine non- responsiveness among health care workers from an endemic area (Taiwan). Liver Int 2005; 25:1162-1168.
Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol 2011; 17:1927-38.
Raimondo G, Caccamo G, Filomia R, Pollicino T.Occult HBV infection. Semin Immunopathol 2013;35:39-52.
Azadmanesh K, Mohraz M, Aghakhani A, Edalat R, Jam S, Eslamifar A, et al. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Intervirology 2008; 51:270-274.
Aghakhani A, Banifazl M, Velayati AA, Eslamifar A, Ramezani A. Occult hepatitis B virus infection in hemodialysis patients: a concept for consideration. Ther Apher Dial 2012; 16:328-33.
Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi AA, McFarland W, et al. A. Viral hepatitis and HIV infection among injection drug users in a central Iranian City. J Addict Med 2012; (4):292-296.
Buchanan C, Tran TT. Management of chronic hepatitis B in pregnancy. Clin Liver Dis 2010; 14:495-504.
Ni YH. Natural history of hepatitis B virus infection.Pediatric perspective. J Gastroenterol 2010; 46:1-8.
Coleman PF. Detecting hepatitis B surface antigen mutants. Emerg Infect Dis 2006; 6:198-203.
Cooreman MP, Leroux-Roels G, Paulij WP. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 2001; 8:237-247.
Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely ‘occult’? Hepatology 2001; 34: 194-203.
Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: a hidden menace? Hepatology 2001; 34:204-6.
Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med 2010;48:23-29.
Raimondo G, Pollicino T, Cacciola I, Squadrito G.Occult hepatitis B virus infection. J Hepatol 2007;46:160-170.
Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, et al. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis 2010;14(4):e308-e310.
World Health Organization: vaccines and biologicals: WHO vaccine preventable disease monitoring system: global summary 2009 data up to 2008). Available at: ww.who.int/immunization/documents/WHO_IVB_2009/en/index.html.Assessed October 10, 2011.
Sande MABvd, Waight P, Mendy M, Rayco-Solon P, Hutt P, Fulford T, et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 2006; 193:1528-1535.
Chang MH. Breakthrough HBV infection in vaccinated children in Taiwan. Surveillance for HBV mutants. Antivir Ther 2010; 15:463-469.
Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998; 27:100-106.
Hsu HY, Chang MH, Ni YH, Chen HL. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 2004; 53:1499-1503.
Sa-Nguanmoo P, Tangkijvanich P, Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Thawornsuk N, et al. Molecular analysis of hepatitis B virus associated with vaccine failure in infants and mothers: a case- control study in Thailand. J Med Virol 2012; 84:1177-85.
Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC.Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan. Vaccine 2012; 30:4034-4039.
Pande C, Sarin SK, Patra S, Kumar A, Mishra S, Srivastava S, et al. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat 2013; 20:801-810.
Mu SC, Lin YM, Jow GM, Chen BF. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 2009;50:264-72.
Ramezani A, Banifazl M, Eslamifar A, Aghakhani A.Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries 2010; 4:658-61.
| Files | ||
| Issue | Vol 6 No 5 (2014) | |
| Section | Articles | |
| Keywords | ||
| HBV HBV core antibody HBV vaccine non-responders Occult HBV infection | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
